Takeda Pharmaceutical (TAK) Shares Outstanding (Diluted) (2017 - 2026)
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Shares Outstanding (Diluted) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 1.23 Bn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | 210.89 Mn |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 208.22 Mn |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 45.80 Mn |
| 10 | Takeda Pharmaceutical | 2.61 Bn | -3.19 Bn | 5.10 Bn | 143.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143.19 Mn |
| Mar 31, 2026 | 143.19 Mn |
| Dec 31, 2025 | 145.94 Mn |
| Sep 30, 2025 | 145.94 Mn |
| Jun 30, 2025 | 145.94 Mn |
| Mar 31, 2025 | 145.94 Mn |
| Dec 31, 2024 | 143.67 Mn |
| Sep 30, 2024 | 143.67 Mn |
| Jun 30, 2024 | 143.67 Mn |
| Mar 31, 2024 | 143.67 Mn |
| Dec 31, 2023 | 142.72 Mn |
| Sep 30, 2023 | 142.72 Mn |
| Jun 30, 2023 | 142.72 Mn |
| Mar 31, 2023 | 142.72 Mn |
| Dec 31, 2022 | 143.38 Mn |
| Sep 30, 2022 | 143.38 Mn |
| Jun 30, 2022 | 143.38 Mn |
| Mar 31, 2022 | 143.38 Mn |
| Dec 31, 2021 | 143.05 Mn |
| Sep 30, 2021 | 143.05 Mn |